Enzyme-based technology that breaks down alcohol in the stomach, targeting ALDH2 deficiency common in East Asia.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Funding round Alcolase (Copenhagen) raised 1.5M euros from Ada Ventures, Delphinus, Antler and angels to advance its enzymatic platform against alcohol intolerance. | $1.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.